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Abstract
This module represents the formalised opinion of the authors and the CARMEN consortium, which identifies
the minimum information required to report the use of electrophysiology in a neuroscience study, for submission
to the CARMEN system (www.carmen.org.uk).
Introduction
Electrophysiology is a technology used to study the
electrical properties of biological cells and tissues.
Electrophysiology typically involves the measure-
ments of voltage change or electrical current flow
on a wide variety of scales from single ion channel
proteins to whole tissues.
This document is a single module, as part of
the Minimum Information about a Neuroscience
investigation (MINI) family of reporting guideline
documents, produced by the CARMEN consortium
(www.carmen.org.uk). A MINI module represents
the minimum information that should be reported
about a dataset to facilitate computational access
and analysis to allow a reader to interpret and criti-
cally evaluate the processes performed and the con-
clusions reached, and to support their experimental
corroboration. In practice a MINI module comprises
a checklist of information that should be provided
(for example about the protocols employed) when
a data set is submitted to the CARMEN system.



































data should be transferred in, nor the structure of
the repository. In this respect a MINI module is
implementation independent definition of a particu-
lar technology and follows the design principles and
presentation format of the MAIPE guidelines [1].
The requirements specification for the electro-
physiology family of techniques is prescriptive in
some respects while maintaining flexibility, allow-
ing the description of a wide range of protocols.
The principles underlying this specification define
the minimum information that should be associated
with data generated from a laboratory based electro-
physiology study, for submission to the CARMEN
system.
The information defined within this document
should facilitate the interpretation, dissemination
and evaluation of electrophysiology data, in the first
instance to meet the consensus requirements within
the CARMEN consortium, and ultimately the wider
Neuroscience community. The reporting require-
ments contained within this document should com-
ply with two general criteria; as outlined in Taylor
et al, 2007 [1];
1. Sufficiency. The MINI reporting require-
ments should require sufficient information
about a dataset and its experimental context
to allow a reader to understand and critically
evaluate the interpretation and conclusions,
and to support their experimental corrobora-
tion.
2. Practicability. Achieving MINI compliance
should not be so burdensome as to prohibit
data submission or use of the CARMEN sys-
tem.
These reporting recomendations cover both
extracellular and intracellular electrophysiology
recordings. Specifically, defining general auditing in-
formation, such as date stamps and responsible per-
sons, the subject under study, the subject task or
stimulus if appropriate, the recording protocol and
the resulting description of time series data. They
do not cover optical electrophysiology techniques of
the process of time series informatics analysis.
Items falling outside the scope of this module
may be captured in complementary modules, which
may be developed in due coursecan be. Note that
subsequent versions of this document may have al-
tered scope, as will almost certainly be the case
for all the MINI modules. The MINI family of
guidelines has been registered with the MIBBI reg-
istry (http://mibbi.sourceforge.net/) and are cur-
rently structured using the FuGE data model [2],
via SyMBA [3].
The following section, detailing the reporting re-








7. Time series data
The glossary table provides a definition for each
checklist item in the MINI guidelines. Examples are
given only to facilitate interpretation and are not in-
tended to be a comprehensive list of the technologies





(a) Date and time






























































i. Target cell type
ii. Confirmed cell type


































The MINI: Electrophysiology minimum reporting re-
quirements for the use of electrophysiology specify
that a significant degree of detail be captured about
the subject, the task or stimulus, the protocol and
equipment used to record the measurements, and a
description of the resulting time series data. How-
ever, it is clear that providing the information re-
quired by this document will enable the effective
interpretation and assessment of electrophysiology
data and metadata and potentially, support experi-
mental corroboration. Much of the information re-
quired herein may already be stored in an electronic
format, or exportable from instrumentation; we an-
ticipate further automation of this process. These
guidelines will evolve. To contribute, or to track
the process of the MINI documents contact the cor-
responding author or view the CARMEN website
www.carmen.org.uk.
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Table 1 - MINI: Electrophysiology Glossary of required items
Classification Definition
1. General features
(a) Date and time The date and time on which the work described was initiated given
in the ISO:8601 representation. YYYY-MM-DDThh:mm:ss
(b) Responsible person or role The (stable) primary contact person for this data set; this could
be the experimenter, lab head, line manager etc. Where respon-
sibility rests with an institutional role (e.g. one of a number of
duty officers) rather than a person, give the official name of the
role rather than any one person. In all cases give affiliation and
stable contact information, which consists of (i) Name, (ii) Postal
address and (iii) Email address.
(c) Experimental context The name of the project, study or wider investigation of which
the ”experiment” is a part (if appropriate).





































2. Study subject (derived from MIAME 1.1 [4])
(a) Genus The genus classification of the study subject according to the
NCBI taxonomy classification
(b) Species The species classification of the study subject according to the
NCBI taxonomy classification
(c) Strain The strain, genetic variant classification of the study subject, if
appropriate. Note this is not cell line (see x.x)
(d) Cell line The identifier for the immortalised cell line, if appropritate.
(e) Genetic characteristics The genotype of the study stubject. Genetics characteristics in-
clude polymorphisms, disease alleles and haplotypes.
(f) Genetic variation The genetic modification introduced in addition to strain, if ap-
propriate.
(g) Disease state The name of the pathology diagnosed in the subject. The disease
state is “normal” if no disease state has been diagnosed.
(h)Clinical information A link, summary or reference to additional clinical information, if
appropriate.
(i) Sex The sex of the subject, in terms of either male, female or
hermaphrodite.
(j) Age The time period elapsed since an identifiable point in the life cycle
of an organism. If a developmental stage is specified the identi-
fiable point would be the beginning of that stage. Otherwise the
identifiable point must be specified. For example, 2 hours post
surgery.
(k) Development stage The developmental stage of the study subject’s life cycle
(l) Subject label If the subject has been chemically labeled or stained; state the
label name.
(m) Subject identifier The type and value of the identifier assigned to the subject.
(m)i. Subject identifier type The type and value of the identifier assigned to the subject. For
example, vendor or patient identifier. For patients, the identifier
must be approved by an Institutional Review Board or appropriate
body.
(m)ii. Subject identifier value The unique string which corresponds to the identifier type.
(n)Associated subject details The organisation (e.g vendor) or individual repsonsible for the
subject.
(o) Preparation protocol The surgical procedure or the preparation protocol implmented
to obtain the specific sample for recording.
(p) Preparation date The date the surgical procedure or the preparation protocol was
performed to obtain the specific sample for recording. Given in





































(a) Location structure The anatomical part or structure of the subject under investiga-
tion or recorded from. For example brain or cell culture.
(b) Brain area If the anatomical structure under study from 3.(a) is the
brain then state the location. If the anatomical structure
under study is the mammalian brain then state the loca-
tion using Neuronames. (http://braininfo.rprc.washington.edu/
aboutfolder/aboutbi.html).
(c) Slice thickness The thickness of the recording slice in milimeters.
(d) Slice orientation State the planes of the slice, in terms of either i) coronal (width
ways), ii) saggital (lengthways parallel to midline) or iii) tangential
(lengthways perpendicular to midline).
(e) Cell type .
(e)i. Target cell type The cell type of the anatomical structure given in 3.(a) under
investigation if non mixed. If mixed the target cell type should be
provided
(e)ii. Confirmed cell type The method of coordinate assignment given in 2.3.1. Reported
as ‘anatomy confirmation’,‘estimation’ or chemical label (this in-
cludes antibodies and staining). The label used should be reported
in section 2.(l). Additional information such as recodings or image
files which also confirm the location can be referenced here.
4. Task (if appropriate)
(a) Protocol A description of the task protocol undertaken by the subject
(b) Sensory conditions The sensory conditions during the task protocol
(c) Equipment The Model Name, Model Number and Manufacturer for equip-
ment used in the task protocol
(d) Recording If the task is recorded state how and what data types are being
recorded
5. Stimulus (if appropriate)
(a) Protocol A description of the stimulus protocol undertaken by the subject
(b) Sensory conditions The sensory conditions during the stimulus protocol
(c) Solutions Description of the solutions used in terms of name, components
with concentrations,(if appropriate).
(d) Equipment The Model Name, Model Number and Manufacturer for spe-
cialised equipment used during the stimulus protocol. If elec-
trode(s) are used then they should be described following the
structure presented in ref x.x





































6. Behavioural event - if appropriate
(a) Event A description of the behavioural event observed
(b) Equipment The equipment use to record the behavioural event, if recorded in
terms of The Model Name, Model Number and Manufacturer.
(c) Behavioural event recording The type of recording of the behavioural event, the file format and
the format encoding.
7. Recording
(a) Protocol A description of the recording protocol
(b) Conditions The subject conditions during the recording. Invivo or invitro
preparation If invivo was it anethesitised or awake? If awake what
was the stimulus condition
(c) Containing device Containing device temperature of the subject or sample (for ex-
ample, a bath): Include temperature if appropriate.
(d) Solutions Description of the solutions used in terms of name, components
with concentrations,(if appropriate).
(e) Solution flow speed The flow speed of the solution described in (ref x.x) in terms of
ml/min.
(f) Recording Equipment
(f)i. Electrode The type of electrode and the Model Name, Model Number and
Manufacturer for specialised equipment
(f)ii. Electrode configuration The configuration or arrangement of the electrode. For example,
a 2-dimensional array. Also state the distance between each elec-
trode. If the study uses voltage clamp in a patch configuration,
state the access resistance (the resistance of the cell membrane,
which is in series with the electrode resistance).
(f)iii. Electrode impedance The electrode range or impedance of the electrode
(f)iv. Amplifier The Model Name, Model Number and Manufacturer of the am-
plifier
(f)v. Filter (if appropriate) The Model Name, Model Number and Manufacturer of the filter
(f)vi. Filter settings (if appropriate) The settings or the parameters of the filter
(f)vii. Recorder The Model Name, Model Number and Manufacturer of the
recorder
8. Time series data
(a) Data format The name of the data format of the time series data and specific
encoding. For example, ASCII or binary encoding.
(b) Sampling Rate The sampling rate of the recording
(c) File location The time series file location should be made available when the
experiment is published, for example, using a Uniform Resource
Identifier (URI) or a Digital Object Identifier (DOI). (Note this
will be achieved automatically via submission to the CARMEN
system).
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